Duodenal Ulcer

Approved for this indication (20)

• diclofenac
• metronidazole
• Bismuth Subcitrate Potassium
• sucralfate
• famotidine
• amoxicillin
• protecadin
• methantheline bromide
• nizatidine
• rabeprazole
• clarithromycin
• Allantoin
• misoprostol
• lansoprazole
• ethoxzolamide
• cimetidine
• omeprazole
• esomeprazole
• tetracycline
• ranitidine

Phase 4 trials (1)

• procaine benzylpenicillin

Phase 3 trials (7)

• ilaprazole
• clavulanate
• geranyl farnesyl acetate
• fluconazole
• vonoprazan
• cefuroxime
• tegoprazan

Phase 2 trials (1)

• mk0782

Phase 1 trials (2)

• d961
• tenatoprazole

Other trials (4)

• acetylsalicylic acid
• oxygen
• clopidogrel
• irsogladine

Organization Involved with Phase 4 Indications (7)

• Livzon Pharmaceutical Group Inc.
• Yung Shin Pharm. Ind. Co., Ltd.
• Central South University
• Columbia University
• National Taiwan University
• Catholic University of Korea
• Government of Taiwan

Organization Involved with Phase 3 Indications (11)

• Eisai
• Sihuan Pharmaceutical Holdings Group Ltd.
• Chulalongkorn University
• Hamamatsu University
• Juntendo University
• Jichi Medical University
• University of Michigan
• University of Bologna
• Peking University
• Nuovo Regina Margherita Hospital
• Yokoyama Foundation for Clinical Pharmacology

Organization Involved with Phase 2 Indications (1)

• Merck

Organization Involved with Phase 1 Indications (5)

• GlaxoSmithKline
• Piramal
• Steba Biotech S.A.
• Hakata Clinic Medical Co. LTA
• Healthcare Discoveries Inc.

Organization Involved with Other Experimental Indications (3)

• Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
• Taipei Veteran General hospital
• The University of Hong Kong